Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases
- Response deadline
- Jul 1, 2026 Closed
- Date posted
- Jun 1, 2026
- Source
- Open notice
Description
This cooperative agreement establishes a single, integrated funding mechanism aimed at enhancing the nation's ability to prevent, detect, and respond to infectious disease threats. It will support clinicians, healthcare professionals, healthcare systems, institutions, and organizations directly involved in patient care, public health, and infectious disease control across the United States. By strengthening the capacity of these key stakeholders, the program will enable more effective frontline engagement, facilitate the implementation of timely public health responses, and generate expert insights to inform and improve public health guidance and practice.The program will focus on building and sustaining critical infrastructure, workforce training, communication strategies, and emergency response capabilities needed to address both emerging and reemerging infectious diseases. Emphasis will be placed on expanding national infection prevention capacity through targeted education and training initiatives, particularly in the areas of antimicrobial resistance and infection control. Additionally, the program will enhance preparedness by supporting surge staffing and fostering coordination among healthcare and public health partners during emergency response efforts.
Classifications
- NAICS93.084
Documents (2)
Contacts
- xki5@cdc.gov770-488-2756
Similar contracts
- US Travelers Health Research, Surveillance, Communication, and Outreach NetworkDue Nov 5, 2026
- Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious DiseasesDue Nov 5, 2026
- Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities.Due Jul 17, 2026
- Increasing awareness and knowledge of Alpha-gal Syndrome in the United StatesDue Jul 9, 2026
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)Due Feb 8, 2028
- NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food SpecimensDue Apr 1, 2027